$ARHS

[Form 4] Arhaus, Inc. Insider Trading Activity

Arhaus, Inc. director Gary L. Lewis increased his equity stake through stock-based compensation events. On May 15, 2026, previously granted Restricted Stock Units and Dividend Equivalent Rights vested and were converted into shares. Additionally, a new grant of 22,960 Restricted Stock Units was awarded on May 14, 2026, which will vest on the first anniversary of the grant date subject to continuous service. Following these transactions, Lewis directly holds 56,511 shares of Class A Common Stock.

Original reporting
Published May 19, 2026, 1:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 19, 2026, 2:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ARHS
Neutral
medium confidence
Mentioned
$ARHS
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$ARHSNeutralMed
01

Why it matters

The recent vesting and new grant suggest ongoing insider commitment, which could positively influence investor perception.

02

Market read

While company-specific, insider activity can influence short-term trading sentiment, especially for active traders.

03

What to watch

Market-wide volatility or upcoming earnings reports could influence stock performance independently of insider activity.

Timing: Short to medium term (next 1-3 months)

Background

Arhaus, Inc. has seen recent stock price stabilization; insider transactions are often viewed as confidence signals.

Company-level read

Ticker impact

$ARHSNeutralMedium confidence
Context

Insider trading activity indicating increased insider confidence.

Expected impact

Moderate upward price movement expected over the next 1-3 months.

Evidence & confidence

Insider buying can indicate confidence; however, the magnitude and context of transactions are moderate, and broader market conditions should be considered.

Market effects

Potential positive sentiment for the specialty retail sector.

Limited regional impact; primarily company-specific.

Minimal global market relevance.

Counterpoint

Insider buying could be a strategic move to support stock price during a period of internal challenges; thus, it may not necessarily indicate future growth.

Key entities

  • Gary L. Lewis

    Director of Arhaus, Inc., involved in recent insider transactions.

  • Arhaus, Inc.

    Retail furniture company with recent insider activity.

Related articles

$ARHSMed

Arhaus’s (NASDAQ:ARHS) Q2 CY2026: Strong Sales, Stock Soars

Arhaus (NASDAQ:ARHS) reported Q2 CY2026 revenue of $384.9 million, up 7.4% year on year and above Wall Street estimates by 4.9%. Next-quarter revenue guidance was $365 million, about 1.6% below analysts’ expectations. GAAP EPS was $0.28, 72.3% above consensus. The stock rose 9.1% to $9.00 after results.

$ARHSMed

Arhaus, Inc. (ARHS): Results of Operations and Financial Condition

Arhaus, Inc. (ARHS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026-earningsrelease.htm EX-99.1 Document ARHAUS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS BOSTON HEIGHTS, Ohio (August 6, 2026)—Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a premium home furnishing brand known for responsibly sourced, artisan-crafted

$AAPLMed

Apple Tests Chinese Memory Chips As Supply Crunch Pushes PC Giants Toward CXMT

The Wall Street Journal reported Apple is testing memory chips from China’s CXMT across iPhones and MacBooks and has held early talks to supply components for some China-sold devices. Apple is seeking White House approval amid “unsustainable” pricing from SK Hynix, Samsung, Micron and SanDisk. US rules limit customization, but off-the-shelf purchases may be allowed.

$MDTMed

Jury Orders Medtronic to Pay $88 Million After Finding Surgeons Were Not Adequately Warned About a Hernia Mesh

A federal jury ordered Medtronic’s Covidien unit to pay $88 million to Larry and Tammy Patterson after finding surgeons were not adequately warned about risks of Covidien’s Symbotex hernia mesh. The Aug. 4 verdict followed a three-week trial in Massachusetts. Jurors awarded $77 million to Larry and $11 million for loss of consortium, with no punitive damages.

$LMTMedAI 8/10

What is Patriot missile system, why its supplies are down

The article explains the U.S.-made Patriot mobile air defense system and why interceptor missile supplies are down. It cites Raytheon and Lockheed for system details and notes CSIS estimates about 65% of U.S. interceptors were expended Feb to July, leaving under 850. It says the U.S. approved 5,250 interceptors for Gulf states and awarded Lockheed a contract up to $58.6B.

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.